Weiss Multi-Strategy Advisers’s PDL BioPharma, Inc. PDLI Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio PDLI Stock Details PDLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-49,720	Closed	-$413K	–	1125
2014 Q1	$413K	Buy	49,720 +23,870	+92%	+$205K	0.01%	742
2013 Q4	$218K	Sell	25,850 -8,550	-25%	-$72.1K	﹤0.01%	893
2013 Q3	$274K	Buy	+34,400	New	+$277K	0.01%	682

Other funds holding PDLI

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

AAM

Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Weiss Multi-Strategy Advisers's PDLI Position: Q2 2014 in Review

Weiss Multi-Strategy Advisers sold out of PDL BioPharma, Inc. (PDLI) in Q2 2014, closing a stake of 49,720 shares — an estimated $413K sold.

Weiss Multi-Strategy Advisers first reported a position in PDLI in Q3 2013 and held it in 3 quarters. The position peaked at $413K in Q1 2014. 222 funds tracked by Wall St. Rank hold PDLI as of Q2 2014.

Weiss Multi-Strategy Advisers reported no remaining PDL BioPharma, Inc. position as of Q2 2014 after selling out during the quarter.
Weiss Multi-Strategy Advisers sold 49,720 PDL BioPharma, Inc. shares in Q2 2014, an estimated $413K.
Weiss Multi-Strategy Advisers first reported a position in PDL BioPharma, Inc. in Q3 2013 and held it in 3 quarters.
Weiss Multi-Strategy Advisers's PDL BioPharma, Inc. position peaked at $413K in Q1 2014.
222 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q2 2014.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q2 2014, filed 14 Aug 2014.